市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | GeoVax Labs, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
1.0
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.00 |
|
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.42% |
| 机构持股比例 | 7.72% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Fiduciary Alliance Llc | 31 Dec 2025 | 1,400 |
| Moneta Group Investment Advisors Llc | 31 Dec 2025 | 800 |
| 52周波幅 | ||
| 中 | 6.00 (257.14%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| D. Boral Capital | 21 Jan 2026 | 6.00 (257.14%) | 购买 | 2.98 |
| 19 Nov 2025 | 6.00 (257.14%) | 购买 | 10.38 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合